Capital Group Private Client Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-23,200
Closed -$2.16M 252
2023
Q3
$2.16M Hold
23,200
0.03% 179
2023
Q2
$2.98M Buy
23,200
+256
+1% +$31K 0.04% 164
2023
Q1
$2.67M Hold
22,944
0.03% 161
2022
Q4
$2.6M Hold
22,944
0.03% 168
2022
Q3
$1.85M Hold
22,944
0.03% 177
2022
Q2
$1.71M Hold
22,944
0.02% 182
2022
Q1
$2.94M Buy
+22,944
New +$2.51M 0.03% 179

Other funds holding DXCM

Capital Group Private Client Services's DXCM Position: Q4 2023 in Review

Capital Group Private Client Services sold out of DexCom (DXCM) in Q4 2023, closing a stake of 23,200 shares — an estimated $2.16M sold.

Capital Group Private Client Services first reported a position in DXCM in Q1 2022 and held it in 7 quarters. The position peaked at $2.98M in Q2 2023. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Capital Group Private Client Services reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Capital Group Private Client Services sold 23,200 DexCom shares in Q4 2023, an estimated $2.16M.
  • Capital Group Private Client Services first reported a position in DexCom in Q1 2022 and held it in 7 quarters.
  • Capital Group Private Client Services's DexCom position peaked at $2.98M in Q2 2023.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Capital Group Private Client Services's 13F filing for Q4 2023, filed 13 Feb 2024.